The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $639,516 in first-year total cost, median $319,758.
Most frequent study sections
- Special Emphasis Panel[ZDA1 JRB-S (M1)]2
Most frequent institutions
- BIOMEDICAL DEVELOPMENT CORPORATION1
- CHARLES RIVER ANALYTICS, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Novel, On-demand VR for Accessible, Practical, and Engaging therapy (NO VAPE)1R44DA059018-01 | BRACKEN, BETHANY K | CHARLES RIVER ANALYTICS, INC., MA | $319,973 | ZDA1 |
| 2023 | Real World Adoption of an OUD Digital Health Therapeutic1R44DA059017-01 | SIEGEL, GREGG | BIOMEDICAL DEVELOPMENT CORPORATION, KY | $319,543 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.